O
Omniome
Biotech & Life Sciences · San Diego, United States · Founded 2013
Developer of an innovative new DNA sequencing platform MoreLess
Omniome operates at the cutting edge of DNA sequencing technology, leveraging advancements in nanotechnology and genomics to deliver unparalleled solutions. The company primarily serves research institutions, healthcare providers, and biotech firms that require precise and efficient DNA sequencing capabilities. Operating in the rapidly growing genomics market, Omniome's business model revolves around the development and sale of high-performance sequencing instruments and consumables. Revenue is generated through the sale of these products, as well as through service contracts and maintenance agreements. The company is known for its collaborative environment, bringing together a team of skilled scientists and engineers dedicated to pushing the boundaries of what's possible in DNA sequencing.
Keywords: DNA sequencing, nanotechnology, genomics, research institutions, healthcare, biotech, sequencing instruments, consumables, innovation, collaboration.
Company overview
Omniome company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2013
- Headquarters
- San Diego, United States
- Employees
- 2
- Open positions
- None listed
- Dealroom signal
- 59.2
Valuation & funding
Omniome funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jul 2021 | $800M | $800M | Pacific Biosciences | — |
| SERIES COther financing | Jan 2020 | $60M | $240M | ARCH Venture Partners · Decheng Capital · Biomatics Capital Partners · Domain Associates | — |
| SERIES BOther financing | Jul 2018 | $60M | $240M | ARCH Venture Partners · Nan Fung Group · Domain Associates · Hillhouse Capital | — |
| SERIES AOther financing | Jan 2016 | $0 | — | Undisclosed | — |
| SEEDOther financing | May 2014 | $0 | — | Undisclosed | — |
Growth signals
Omniome website traffic
Latest recorded traffic for Omniome is 230 monthly website visits, down 69.7% over the last three months. Omniome's team declined 88.9% over the past year.
Comparisons
Omniome compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Omniome's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Omniome has talent and traffic
team presence
In the news
Latest news about Omniome
Recent press, funding announcements, and product moves mentioning Omniome — open to read from the original sources.
Market sentiment
What the market is saying about Omniome
An AI-synthesized read of the highest-engagement posts about Omniome on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Omniome’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.